03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Rina Syrup : | |
Type | Medicine Authorised |
Originator | Aerius Oral Solution |
Agent | Sadco |
Distributor | Sadco |
Laboratory | Dar Al Dawa |
Responsible Party | Dar Al Dawa Development & Investment Co Ltd |
Origin | Jordan |
Manufacturer | Dar Al Dawa Development & Investment |
Manufacturing Type | G |
Origin | Jordan |
ATC | R06AX27 |
Rina Syrup :
Rina Syrup :
Rina Syrup :
Rina Syrup :
Rina Syrup :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Very rare |
Anaphylaxis | Very rare |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Very rare |
Arrhythmia | Not known |
Asthenia | Not known |
Blood bilirubin increased | Very rare |
Bradycardia | Not known |
Diarrhoea (Diarrhea) | Very rare |
Dizziness | Very rare |
Dry mouth (Xerostomia) | Common |
Dyspepsia | Very rare |
Dyspnoea (dyspnea) | Very rare |
ECG QT prolonged | Not known |
Fatigue | Common |
Hallucination | Very rare |
Headache | Common |
Hepatic enzyme increased | Very rare |
Hepatitis | Very rare |
Hypersensitivity reactions | Very rare |
Insomnia | Very rare |
Jaundice | Not known |
Myalgia | Very rare |
Nausea | Very rare |
Palpitations | Very rare |
Photosensitivity | Not known |
Pruritus | Very rare |
Psychomotor hyperactivity (Psychomotor restlessness) | Very rare |
Seizures | Very rare |
Skin rash | Very rare |
Somnolence | Very rare |
Tachycardia | Very rare |
Urticaria | Very rare |
Vomiting | Very rare |
Rina Syrup :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Rina Syrup MoH 9746 :
Form | Syrup |
Packaging | Bottle |
Package Size | 100ml |
Strength | 0.5mg/ml |
Public Price | 159917.26 L.L. |
Stratum | A1 |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 84716/1 |
Submission date | 17/06/2016 |
Registration Year | 30/01/2019 |
Pending Year | 08/02/2018 |
Pending Reason | Incomplete file |
Rejection Year | 06/09/2017 |
Rejection Reason | Incomplete study |
Price Comparison
● Country: | Lebanon | |
● Form: | Syrup | |
● Package Size: | 100ml | |
● Public Price: | 159917.26 LBP | ( 159,917.26 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 1599,17 LBP | ( 1,599.00 LBP ) |
● Pricing Date: | 13/06/2024 |
● Country: | Jordan | |
● Package Size: | 100ml | |
● Public Price: | 2.71 JOD | ( 339,348.91 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 0,0271 JOD | ( 0.00 LBP ) |
● Pharmacy Price: | 2.07 JOD | ( 259207.47 LBP ) |
● Reference: | JFDA | |
● Pricing Date: | 02/01/2021 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 100ml | |
● Public Price: | 9.55 SAR | ( 225,762.00 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 0,0955 SAR | ( 0.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Oman | |
● Package Size: | 1x100ml | |
● Public Price: | 1.03 OMR | ( 237,656.02 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 0,0103 OMR | ( 0.00 LBP ) |
● Pricing Date: | 19/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Qatar | |
● Package Size: | 100 ml | |
● Public Price: | 10 QAR | ( 245,580.00 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 0,1 QAR | ( 0.00 LBP ) |
● Pharmacy Price: | 7.778447924 QAR | ( 191023.12411759 LBP ) |
● Pricing Date: | 28/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Bahrain | |
● Package Size: | 100ML | |
● Public Price: | 0.91 BHD | ( 216,337.94 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 0,0091 BHD | ( 0.00 LBP ) |
● Reference: | nhra | |
● Pricing Date: | 09/02/2021 | |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File